![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, June 24, 2015 9:06:34 PM
'Favourable' biotech corn seed data send Ceres shares soaring
By Agrimoney.com - Published 09/01/2015
Ceres' flagging shares rebounded by one-third after the seed group revealed that genetically modified corn it is researching in China had shown a 25% jump in yields, potentially opening up "an exciting area for value creation".
The US-based group - which in November, soon after harvesting field trials of its biotech corn said that results appeared "positive" – said on Friday that many of its plots had achieved a "25% yield advantage" over unnamed alternative varieties planted as controls.
"A second year of field trials demonstrated significant yield advantages," Ceres said, adding that the improvements had been evident in both normal and drought conditions.
The group, which unlike some other seed developers promotes the mixing of its genetically modified traits, said that the best combinations faced "broader field evaluations" next year.
'Critical stage'
The results in what Ceres termed a "critical stage" of the biotech seed development process, offering "greater insight into how traits may perform in an agricultural setting", represented an "exciting area for value creation".
"Double-digit percentage increases in highly bred corn hybrids are urgently needed in a crop where a few percentage point increases are the norm," said Richard Flavell, the Ceres chief scientific advisor.
The group also said it may attempt to licence to other biotech seed groups its iCode technology which enhances the testing of multiple genetically modified traits.
The promising gene combinations flagged up by iCode "may well" enable large increases in yields, "and shape crop biotechnology for years to come," Dr Flavell said.
Shares jump
The results of the corn trials, which were undertaken in China with the Chinese Academy of Agricultural Sciences, prompted a 33% jump to $0.3195 in Ceres shares in early deals in New York.
The shares stood up 16.8% at $0.2803 in afternoon deals.
Ceres stock last month hit an all-time low of $0.21, well below the high of $18.70 reached in March 2012, soon after the company floated.
Recent CERE News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 08:17:51 PM
- Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson’s Disease • GlobeNewswire Inc. • 04/18/2024 10:30:00 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/27/2024 09:02:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:46:54 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/09/2024 02:00:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 12:19:13 AM
- Kuehn Law Encourages MDC, WAVD, NS and CERE Investors to Contact Law Firm • PR Newswire (US) • 01/24/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:51:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:50:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:46:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:37:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:34:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:31:30 PM
- Form DEFM14A - Definitive proxy statement relating to merger or acquisition • Edgar (US Regulatory) • 01/18/2024 12:44:59 PM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 01/18/2024 12:19:35 PM
- Form PREM14A - Preliminary proxy statements relating to merger or acquisition • Edgar (US Regulatory) • 01/05/2024 10:13:35 PM
- Kuehn Law Encourages CERE, HA, IMGN, and WAVD Investors to Contact Law Firm • PR Newswire (US) • 01/02/2024 11:10:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 09:15:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 09:15:10 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/26/2023 10:03:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2023 01:27:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2023 01:21:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2023 01:14:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2023 01:12:28 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2023 01:10:04 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM